Market Overview

20 Stocks Moving In Tuesday's Pre-Market Session

Share:

Gainers

  • Lipocine Inc (NASDAQ: LPCN) rose 35.1 percent to $5.43 in pre-market trading as the company disclosed that LPCN 1021 met its primary endpoint.
  • Neos Therapeutics Inc (NASDAQ: NEOS) shares rose 10 percent to $9.90 in pre-market trading as the company reported the FDA approval of Cotempla XR-ODT extended-release orally disintegrating tablets for the treatment of ADHD in patients 6 to 17 years old.
  • PAREXEL International Corporation (NASDAQ: PRXL) shares rose 8.1 percent to $90.68 in pre-market trading after WSJ reported that Pamplona Capital Management is near a deal to acquire the company for $88.10 per share.
  • Bellicum Pharmaceuticals Inc (NASDAQ: BLCM) rose 8 percent to $13.93 in pre-market trading after surging 13.86 percent on Monday.
  • Vivint Solar Inc (NYSE: VSLR) rose 6.9 percent to $4.65 in pre-market trading. Goldman Sachs upgraded Vivint Solar from Neutral to Buy.
  • Lion Biotechnologies Inc (NASDAQ: LBIO) shares rose 6.1 percent to $7.00 in pre-market trading after gaining 10.00 percent on Monday.
  • China Techfaith Wireless Comm. Tech. Ltd (NASDAQ: CNTF) rose 5.1 percent to $3.49 in pre-market trading after climbing 6.75 percent on Monday.
  • LG Display Co Ltd. (ADR) (NYSE: LPL) shares rose 5 percent to $17.17 in the pre-market trading session after falling 0.30 percent on Monday.
  • Ichor Holdings Ltd (NASDAQ: ICHR) rose 4.6 percent to $25.00 in pre-market trading after gaining 4.36 percent on Monday.
  • Lennar Corporation (NYSE: LEN) rose 4.1 percent to $54.87 in pre-market trading after the company reported stronger-than-expected results for its second quarter.
  • Marvell Technology Group Ltd. (NASDAQ: MRVL) rose 3.1 percent to $17.99 in pre-market trading. Pacific Crest upgraded Marvell Technology from Sector Weight to Overweight.
  • Tesla Inc (NASDAQ: TSLA) shares rose 2.6 percent to $379.30 in pre-market trading following a report that the company is near a deal related to plan for China production plant.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • AveXis Inc (NASDAQ: AVXS) fell 5.6 percent to $68.00 in pre-market trading. AveXis reported a $200 million share common stock offering.
  • Workhorse Group Inc (NASDAQ: WKHS) shares fell 4 percent to $3.88 in pre-market trading after declining 0.25 percent on Monday.
  • LendingClub Corp (NYSE: LC) fell 4 percent to $5.55 in pre-market trading after rising 3.03 percent on Monday.
  • Prudential Public Limited Company (ADR) (NYSE: PUK) shares fell 3.3 percent to $44.76 after rising 0.56 percent on Monday.
  • Galapagos NV (ADR) (NASDAQ: GLPG) fell around 2.7 percent to $79.54 in pre-market trading after gaining 3.69 percent on Monday.
  • Clovis Oncology Inc (NASDAQ: CLVS) shares fell 2.7 percent to $85.50 in pre-market trading after surging 46.54 percent on Monday. Clovis Oncology reported a $250 million offering of common stock.
  • Regeneron Pharmaceuticals Inc (NASDAQ: REGN) shares fell 2.5 percent to $460.00 in the pre-market trading session after rising 2.56 percent on Monday.
  • Vipshop Holdings Ltd - ADR (NYSE: VIPS) fell 2.4 percent to $11.61 in pre-market trading after gaining 0.85 percent on Monday.

Posted-In: #PreMarket Gainers LosersNews Movers & Shakers Pre-Market Outlook Markets Movers

 

Related Articles (BLCM + AVXS)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Fibrocell Science (FCSC) Looks Good: Stock Moves Up 13.9%

Carnival (CCL) to Report Q2 Earnings: What's in the Cards?